ALERT: Fake Drug Series Report Received from AATA
The Health and Labor Inspection Body of Armenia warns citizens that there has been a case of counterfeiting in the Swiss drug "Perjeta" series No. 7796, and it is advised to refrain from using it.
According to letter No. 01/2457-26 received on May 11, 2026, from the State Expert Center for Medicines and Medical Technologies, Hoffmann-La Roche AG provided information regarding the counterfeiting of the drug Perjeta (pertuzumab) concentrate for solution for intravenous administration, 30 mg/ml, glass vial 14 ml (registration certificate holder: F. Hoffmann-La Roche Ltd, Switzerland) series No. 7796.
Dear citizens, please be attentive and avoid using the drug of series No. 7796.
Նմանատիպ հոդվածներ
Criminal Prosecution Against 19-Year-Old Driver
The Prosecutor's Office of Armenia has initiated public criminal proceedings against 19-year-old Vahram Markosyan, who d...
Hantavirus Situation in Armenia: Details
The World Health Organization reports that on May 2, an alert was received from the United Kingdom's national health coo...
Video: Deputy Director of Yerevan Zoo Discusses Today's Incident
The zebras are in place and are well taken care of; they have no need to escape. This was stated by the deputy director...
Airplane Evacuated Due to Wi-Fi Network Name
A KLM flight from Malaga to Amsterdam was evacuated after the discovery of the word "bomb" in the name of a Wi-Fi networ...
Ավելին Society բաժնից
Mass Power Outages in Georgia
Heat is Dangerous for the Heart
Nighttime Operations, Alcohol and Tobacco Sales: Violations Registered in Yerevan
